6月24日 - ** 药物开发商Candel Therapeutics的CADL.O股价大涨5.4%至4.92美元
** CADL同意以每股4.67美元的价格出售320万股 (link)，募集资金总额为1500万美元。
** 周一股价下跌 1.7%，收于 4.67 美元
** 现有机构投资者和 CADL 高管参与了此次发行
** 募集资金将用于支持其前列腺癌疗法 CAN-2409 的预商业化和上市准备活动
** 所有4家券商对该公司股票的评级均为 "买入 "或更高；PT中值为22美元--数据由LSEG编制
** 截至上次收盘，CADL股价累计下跌46.2
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.